Skip to content

Author

L. Kachnic

We have 2 of 39 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Oct 2026

Abstract B059: Patient-reported barriers to clinical trial enrollment: A site-level analysis of DCP-001 non-enrollees at an academic medical center

Understanding why eligible patients with cancer decline clinical trial participation is critical to developing targeted accrual interventions. DCP-001 is a National Cancer Institute (NCI) Division of Cancer Prevention protocol within the NCI Community Oncology Research Program (NCORP). The protocol systematically...

J. Kahn, M. Beauchemin, Erik Harden et al. · 0 citations
Aug 2026

Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas.

PURPOSE Age ≥40 years is regarded as a high-risk feature and an indication for adjuvant chemoradiotherapy for patients with lower-grade glioma in clinical practice guidelines. It is unclear whether age remains a relevant prognostic factor for contemporary definitions of lower-grade gliomas in the molecular era. METHO...

C. Kinslow, G. Minniti, P. Brown et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.